首页> 外文期刊>Journal of Immunological Methods >The pre-analytical processing of blood samples for detecting biomarkers on protein microarrays
【24h】

The pre-analytical processing of blood samples for detecting biomarkers on protein microarrays

机译:血液样品的分析前处理,用于检测蛋白质微阵列上的生物标记

获取原文
获取原文并翻译 | 示例
           

摘要

Specimen collection method and quality insurance are pivotal in biomarker discovery. Pre-analytical variables concerning blood collection and sample handling might affect analytical results and should be standardised prior application. In this study, we examine pre-analytical characteristics of blood samples using protein microarray. The influences of 1) standby times until centrifugation (1 h, 4 h, 24 h and 48 h), 2) four blood collection methods, and 3) IgG purified from those samples on differentially reactive antigens between samples ("DIRAGs") were investigated. Spearman correlation analyses of intra-individual arrays demonstrated remarkable differences (0.75-0.98 vs. 0.5-0.75) of antibody reactivities within and between serum and plasma samples. Class comparison showed that reactive antigen profiles were best preserved using IgG purified samples of serum tubes without separation gel as after 24 h 83% of the 1 h baseline DIRAGs were re-found. Testing dilution series with protein microarrays and Luminex xMap (R) Technology, we found linear correlations (R-2 = 0.94-0.99) between IgG concentration and read-out when using purified IgG instead of serum. Therefore, we highly recommend standardising pre-analytics and proposing the use of purified IgG for autoantibody immune-profiling with protein microarrays to reduce potential unspecific binding of matrix proteins abundant in serum and plasma samples. Significance: Although purified IgG cannot completely compensate the influence of pre-analytics, in highly parallel immune-profiling IgG enables reduction of unspecific effects, which occur when using serum or plasma for analysis on protein microarrays. Reproducibility problems due to pre-analytical processing of blood samples might explain discrepant results reported in various biomarker studies. (C) 2015 Elsevier B.V. All rights reserved.
机译:标本采集方法和质量保证在生物标记物发现中至关重要。有关采血和样品处理的分析前变量可能会影响分析结果,应在应用前进行标准化。在这项研究中,我们使用蛋白质微阵列检查了血液样本的分析前特征。对以下因素的影响是:1)离心分离的待机时间(1 h,4 h,24 h和48 h),2)四种采血方法以及3)从这些样品中纯化的IgG对样品之间的差异反应性抗原(“ DIRAG”)的影响调查。单个阵列内的Spearman相关分析表明,血清和血浆样品之间以及之间的抗体反应性差异显着(0.75-0.98对0.5-0.75)。类别比较显示,使用IgG纯化的无分离凝胶的血清试管样品可以最好地保留反应性抗原谱,因为在24 h之后,重新发现了1小时基线DIRAG中的83%。用蛋白质微阵列和Luminex xMap(R)技术测试稀释系列,我们发现当使用纯化的IgG代替血清时,IgG浓度与读数之间存在线性关系(R-2 = 0.94-0.99)。因此,我们强烈建议标准化预分析,并建议使用纯化的IgG用于蛋白质微阵列进行自身抗体免疫分析,以减少血清和血浆样品中大量基质蛋白的潜在非特异性结合。启示:尽管纯化的IgG不能完全补偿预分析物的影响,但在高度平行的免疫谱分析中IgG可以减少非特异性作用,这种作用是在使用血清或血浆对蛋白质微阵列进行分析时发生的。由于对血液样本进行了分析前处理而导致的再现性问题可能解释了各种生物标记研究中报告的差异结果。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号